Platelet Transfusion
Publication Date: November 28, 2017
Key Points
Key Points
Prophylactic platelet transfusion should be administered to patients with thrombocytopenia resulting from impaired bone marrow function to reduce the risk of hemorrhage when the platelet count falls below a predefined threshold level.
Recommended thresholds for prophylactic platelet transfusion are provided for patients with hematologic malignacies or solid tumors, and those undergoing hematopoietic stem cell transplantation or invasive procedures.
Guidance is also provided regarding the production of platelet products, prevention of Rh alloimmunization, and management of refractoriness to platelet transfusion.
Recommended thresholds for prophylactic platelet transfusion are provided for patients with hematologic malignacies or solid tumors, and those undergoing hematopoietic stem cell transplantation or invasive procedures.
Guidance is also provided regarding the production of platelet products, prevention of Rh alloimmunization, and management of refractoriness to platelet transfusion.
Treatment
...reatment
...ration of Platelet ProductsPlatelets for transf...
...vention of Rh AlloimmunizationUPDA...
...koreductionUPDATED. The incidence of a...
...phylactic vs Therapeutic Platelet TransfusionP...
...fusion Threshold in Patients with Hematologic...
...sfusion Threshold in the Setting of Hematopoieti...
...elet Transfusion in Patients with Chr...
...let Transfusion Threshold in Patients Wit...
...unt at which Surgical or Invasive P...
...ing for Refractoriness to Platelet Transfusio...
...ng Refractoriness to Platelet TransfusionAlloi...